相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cladribine and pregnancy in women with multiple sclerosis: The first cohort study
Karen Dost-Kovalsky et al.
MULTIPLE SCLEROSIS JOURNAL (2023)
Family planning considerations in people with multiple sclerosis
Kristen M Krysko et al.
LANCET NEUROLOGY (2023)
Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry
Kerstin Hellwig et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)
Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy
Kerstin Hellwig et al.
JAMA NETWORK OPEN (2022)
Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
Sigal Kaplan et al.
DRUG SAFETY (2022)
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Monica Margoni et al.
JOURNAL OF NEUROLOGY (2022)
Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis - COBRA study
Andrea Ines Ciplea et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study
Emmanuelle Pauliat et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders A cohort study from Germany
Tania Kuempfel et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden
Marta Korjagina et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Early Aggressive Treatment Approaches for Multiple Sclerosis
Alexandra Simpson et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2021)
Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation
Undine Proschmann et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience
Sandra Vukusic et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis
Riley Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
Kerstin Hellwig et al.
JOURNAL OF NEUROLOGY (2020)
Pregnancy and Multiple Sclerosis: An Update on the Disease Modifying Treatment Strategy and a Review of Pregnancy's Impact on Disease Activity
Guoda Varyte et al.
MEDICINA-LITHUANIA (2020)
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety
Gavin Giovannoni et al.
DRUG SAFETY (2020)
Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort
Annette Langer-Gould et al.
NEUROLOGY (2020)
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder
Andrea Ines Ciplea et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Safety of potential breast milk exposure to IFN-β or glatiramer acetate One-year infant outcomes
Andrea Ines Ciplea et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years
Jiwon Oh et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
An alternative to product-specific pregnancy registries? PRIM; PRegnancy outcomes Intensive Monitoring
Yvonne Geissbuehler et al.
REPRODUCTIVE TOXICOLOGY (2020)
Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
Despoina Florou et al.
BRAIN SCIENCES (2020)
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
Kottil Rammohan et al.
DRUGS (2020)
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
Ai-Lan Nguyen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Multiple sclerosis and pregnancy
Priya Kanagaraj et al.
OBSTETRICIAN & GYNAECOLOGIST (2019)
Natalizumab during pregnancy and lactation
Undine Proschmann et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Natalizumab during pregnancy and lactation
Undine Proschmann et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment
J. Frau et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
Ralf Gold et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
Ralf Gold et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding
Rhonda Voskuhl et al.
NEUROTHERAPEUTICS (2017)
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
Susan Friend et al.
BMC NEUROLOGY (2016)
Glatiramer acetate during early pregnancy: A prospective cohort study
Sandra Herbstritt et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Glatiramer acetate during early pregnancy: A prospective cohort study
Sandra Herbstritt et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis
Teresa E. Baker et al.
JOURNAL OF HUMAN LACTATION (2015)
Multiple sclerosis and pregnancy in the 'treatment era'
Sandra Vukusic et al.
NATURE REVIEWS NEUROLOGY (2015)
Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis A Randomized Clinical Trial
Jeffrey Cohen et al.
JAMA NEUROLOGY (2015)
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use
Eva Havrdova et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Pregnancy outcomes in patients exposed to interferon beta-1b
Rebecca S. Romero et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience
Ralf Gold et al.
NEUROLOGY AND THERAPY (2015)
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
Goeril Karlsson et al.
NEUROLOGY (2014)
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events
P. K. Coyle et al.
BMJ OPEN (2014)
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects
Jiwon Oh et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2014)
Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing-Remitting Multiple Sclerosis
Bernd C. Kieseier et al.
NEUROLOGY AND THERAPY (2014)
Initiating oral fingolimod treatment in patients with multiple sclerosis
Barry A. Singer
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study
E. Le Page et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes
Heidi J. Salminen et al.
JOURNAL OF NEUROLOGY (2010)
Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study
C. Weber-Schoendorfer et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study
E. Cocco et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
分享论文
